Friday, July 31, 2026

Is o3 Really That Smart? Experts Question OpenAI’s AI Scores

OpenAI's o3 AI model faces scrutiny over benchmark discrepancies, raising concerns about reliability in the AI industry.

Unlocking the Future: How Hyundai Glovis’ Remote Navigation Technology Could Save Up to 3.9% in Fuel Costs

Hyundai Glovis is testing remote navigation for autonomous shipping, collaborating with partners to enhance navigation technology for PCTCs.

Nikola Jokic’s Future: Will the NBA Superstar Sign a Supermax Deal with Denver?

NBA star Nikola Jokic aims to finish his career with the Nuggets, planning to discuss a contract extension next summer.

Tag: development

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Naver to remove Chinese components from AI models, fully adopt in-house vision encoder

Naver will replace its controversial Chinese vision encoder with a self-developed one to enhance its AI models for Korean language and culture.

YH35995: A Game-Changer for Gaucher Disease? FDA Grants Orphan Drug Designation

Yuhan Corp's YH35995 for Gaucher disease receives orphan drug designation, enhancing its development for rare diseases with unmet needs.

Samjin Pharmaceutical and Ewha Womans University Seoul Hospital Sign MOU for Innovative Migraine Treatment

Samjin Pharmaceutical partners with Ewha Womans University Medical Center to develop treatments for CNS disorders, focusing on migraines.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

HLB Life Science R&D: Leading the Charge in CBD Pharmaceutical Development in 2026

HLB Life Science R&D partners for a national project to develop medical cannabis-based pharmaceuticals, focusing on CBD production.

AI-Designed Proteins: How KAIST’s Breakthrough Could Revolutionize Disease Diagnosis and Drug Development

KAIST's Professor Lee Kyu Ri has designed AI-based artificial proteins for specific compound recognition, enabling advanced biosensors.

Unlock Coding Power: OpenAI Launches 100 USD ChatGPT Pro Plan for Heavy Users

OpenAI launches a $100/month ChatGPT Pro plan for developers, enhancing Codex usage and coding capabilities for complex projects.

Samsung Bioepis Launches AI Academy: How 1,000 Employees Will Master AI by July 2026

Samsung Bioepis launches an AI training program for employees to enhance skills in biopharmaceuticals, boosting global competitiveness.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

K-Beauty Revolution: Jenecell’s Stem Cell Skincare Launch in 2026

Jenecell launches a K-beauty skincare line, partnering with Helios for stem cell culture medium to enhance product performance and market reach.

HLB Genex and KAIST Join Forces: Revolutionary Brain Health Solutions in 2026

HLB Genex partners with KAIST to develop innovative brain health solutions, merging research with commercialization to address social challenges.

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

GC Biopharma Develops Innovative Method to Enhance Immunoglobulin Safety

GC녹십자 developed a method to detect impurities that can cause blood clots in the production of intravenous immunoglobulin.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.